Skip to main content
. 2012 Jul 13;19(12):1992–2002. doi: 10.1038/cdd.2012.89

Table 2. Transcription factors predicted to have their binding sites in the vicinity (±100 bp) of the p53-binding sites.

Commmon for induced and repressed
Unique for induced
Unique for Repressed
Factor N sites per 1 kbp Enrich P-value Factor N sites per 1 kbp Enrich P-value Factor N sites per 1 kbp Enrich P-value
AHR 0.7117 1.8792 0.001829 BACH2 0.2491 2.587 0.0098112 ARNT 1.7143 2.811 3.59E-05
AP2 5.1246 3.1678 9.43E-40 ETV7 2.9181 1.3733 0.0006481 BCL6 2.0714 1.9207 0.0017116
AP4 1.2278 1.6777 0.0006008 HAND1 4.1815 1.494 7.40E-07 DEAF1 0.2143 33.38 0.0021042
AR 0.3559 2.1322 0.0095111 HNF1A 0.1779 3.9597 0.0049341 HIF1A 1.2143 2.6642 0.0007813
CP2 4.7865 1.6139 7.10E-10 AP1 0.4804 2.5806 0.0004129        
CREB/ATF 1.9217 1.7404 7.09E-06 MAF 0.1779 6.9295 0.0005729        
E2F 1.2278 3.4153 1.15E-11 MAZ 0.7117 2.174 0.0002464        
EBF 0.9431 2.2258 1.73E-05 MYOG 5.8541 1.416 2.89E-07        
EGR1 0.8363 3.7221 3.98E-09 NFKB 1.121 1.7289 0.0005755        
ETS1 1.3701 2.1558 6.09E-07 NR3C1 0.1068 16.631 0.0018787        
HIC1 0.4804 3.7419 7.46E-06 PAX6 8.2206 1.177 0.0020025        
NR5A2 1.1744 1.5373 0.0037999 SMAD3 4.6085 1.2729 0.0008693        
PAX3 5.8363 1.2877 0.0001103 SP3 4.2705 1.974 3.22E-15        
PAX4 1.2811 1.5234 0.0030804 ZBTB33 0.2491 2.985 0.0044078        
PAX5 6.9751 1.6266 5.52E-14                
PPARA 6.4057 1.2319 0.000642                
SP1 1.1566 5.4596 2.06E-16                
STAT 2.2143 1.8347 0.0022804                
TEAD-2 1.2989 3.0658 7.00E-11                
TP53 3.2562 8.0514 4.66E-55                
V-MYB 0.8541 2.2174 4.48E-05                
VDR 4.7687 1.6693 6.62E-11                
WT1 7.0463 2.3304 8.54E-34                
ZBTB7A 10.854 1.6118 3.70E-20                
ZF5 7.8114 3.3521 6.24E-64                
ZFP67 0.7651 11.919 1.58E-16                
ZIC3 7.8114 1.4215 2.58E-09                

Expression level after nutlin3a treatment: underlined – induced; bold – repressed; plain – no changes.